long-acting EPO (UBI Pharma)
长效促红细胞生成素 (UBI Pharma)
Report date: 2024/01/09 17:50:03
Base Information
Drug Namelong-acting EPO (UBI Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUbi Pharma
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A